Washington Report: After Plan B: Out of the Quagmire, into the Data - Pharmaceutical Executive

ADVERTISEMENT

Washington Report: After Plan B: Out of the Quagmire, into the Data
The morning-after pill goes OTC, with some special requirements. But is FDA's drug information system up to the task of tracking how it is used?


Pharmaceutical Executive


While it may take several years to finalize the e-registration rule, FDA plans to start accepting electronic listings on a voluntary basis. In addition to all the envisioned benefits, a more efficient drug registration system would free FDA resources to implement the new policy and ensure compliance with the rules. Such possibilities are sure to generate many public comments.

Jill Wechsler is Pharm Exec's Washingtoncorrespondent. She can be reached at


ADVERTISEMENT

blog comments powered by Disqus

Source: Pharmaceutical Executive,
Click here